Status:

COMPLETED

Dermatological Evaluation of Topic Compatibility-Dermacyd Delicata Pocket BR

Lead Sponsor:

Sanofi

Conditions:

Healthy

Eligibility:

FEMALE

18-60 years

Phase:

PHASE3

Brief Summary

The purpose of this study is to demonstrate the absence of irritation potential (primary dermal irritability and cumulated dermal irritability) and allergy (sensibilization) of the product Dermacyd Po...

Eligibility Criteria

Inclusion

  • Phototype Skin I,II, III e IV
  • Integral skin test in the region

Exclusion

  • Lactation or gestation
  • Use of Antiinflammatory and/or immunosuppression drugs
  • Personnel history of atopy
  • History of sensitivity or irritation for topic products
  • Active cutaneous disease
  • Use of new drugs or cosmetics during the study
  • The above information is not intended to contain all considerations relevant to a patient's potential participation in a clinical trial.

Key Trial Info

Start Date :

November 1 2007

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

Estimated Enrollment :

52 Patients enrolled

Trial Details

Trial ID

NCT00668460

Start Date

November 1 2007

Last Update

January 29 2009

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Sanofi-aventis administrative office

São Paulo, São Paulo, Brazil

Dermatological Evaluation of Topic Compatibility-Dermacyd Delicata Pocket BR | DecenTrialz